VeriMomVeriMom

r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)은 임신 중 안전한가요?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).

성분
r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)
알려진 위험 없음
100
/100
0

Related ingredients

Frequently asked questions

r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)은 임신 중 안전한가요?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).
r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)은 모유 수유 중 안전한가요?
Same rationale as pregnancy: no harmonised classifications or authoritative cosmetic safety assessments indicating reproductive/lactation risk. Large peptide molecules used topically have low systemic availability; no data indicate transfer into breast milk or effects on nursing infants.
r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)은 아기 피부에 안전한가요?
No evidence of intrinsic reproductive or developmental hazard. Mechanistic data lacking. Exposure score increased by +1 for infants (e=1) because, although adult dermal absorption is expected to be negligible for large peptides, infant skin has higher absorption potential and immature barrier function, so measurable exposure cannot be excluded.
VeriMom은 r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)을 100/100 (알려진 위험 없음)로 평가합니다.
임신 중 r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요